Skip to content
Noroxi
CVE.org (no NVD analysis yet)· CNA ibm

CVE-2026-123218: IBM Aspera Faspex Authorization Bypass

CriticalCVSS 9.8 · v3.1KEVWeaponized No fix recorded

Noroxi assessment

Priority: This week (action score 69/100)

  • CISA has confirmed exploitation in the wild (Nov 9, 2026). Remediation deadline for US federal agencies: Nov 12, 2026.
  • Probability of exploitation in the next 30 days: 0.53% (FIRST EPSS).
  • Anyone who can reach it over the internet can trigger it. No account or password is required. No user action is required. No special conditions are required; it is repeatable.
  • According to CISA the attack is automatable: targets can be found by mass scanning.
  • According to the record, no fixed version is available yet.

Don’t wait for the next maintenance window. Until a fix is released, restrict access to the affected component and follow the vendor's advisory.

Generated automatically from the record's data: CVSS (NVD and CNA), CISA KEV and SSVC, FIRST EPSS, exploit sources, fixed versions. How we calculate it

Primary sources: NVD · CVE.org · CISA KEV · FIRST EPSS

IBM Aspera Faspex 5.0.0 through 5.0.19 could allow an authorized user to craft a specific message to bypass user authorization and gain full administrative privileges.

Published
Nov 7, 2026
Updated
Nov 10, 2026
EPSS
0.5% · 45th percentile

Report tools

JSON

Action score

69

This week

Don’t wait for the next maintenance window.

CVSS
39 / 40 · 9.8 / 10
CISA KEV
30 / 30 · Listed
EPSS
0 / 30 · 0.5%

CISA SSVC decision

Exploitation
active
Automatable
yes
Technical impact
total

Vulnrichment: CISA's decision-tree inputs.

CNA vs NVD score

NVD
—
CNA · ibm
9.8
NVD has not scored this yet; the score shown is the CNA’s.

The score given by the assigning authority versus NVD’s independent score. A gap means the severity is contested.

Actively exploited in the wild

CISA added this to its Known Exploited Vulnerabilities catalog on Nov 9, 2026. That signals real attacks, not theory.

Remediation deadline for US federal agencies: Nov 12, 2026.

Get told when this record changes

  • In CISA KEV: exploitation in the wild confirmed
  • Weaponized exploit exists
  • No fixed version yet

If any of these changes, we'll tell you in the daily email digest.

Follow CVE-2026-123218

When you'll hear from us

  • when it enters CISA KEV
  • when exploit code appears or is weaponized
  • when the record is updated (including a fixed version)
  • when EPSS rises 20 points in a week

One daily email digest (06:00 UTC); connect a webhook for KEV listings and weaponized exploits every 10 minutes on paid plans, on the hour on the free plan.

Your free account also gets you

  • CVE alerts: add the products and versions you run, get the new CVEs that affect them
  • Uptime monitoring: 1 site, instant email when it goes down
  • Add your domain: subdomains and takeover risk scanned every week (1 domain)
  • 10 scans an hour on the security tools, at most 30 a day (3 a day without an account), an API key and MCP
  • All your scans in one panel: findings, what changed in the last scan, a report per domain or per client (PDF, share link)
All free tools

Sign up with email · Have an account? Sign in

Free account, no card. Unfollow any time.

Don't want an account? Get "Exploited this week" by email every MondayDon't want an account? RSS feed for ibm records
Is your version affected? Check it

Noroxi analysis

What does it mean in your environment?

The assessment above is generated automatically from the record's data; it doesn't know your environment. Our team verifies on your systems whether this vulnerability is actually exploitable and which mitigation is enough.

We use this product, ask for help

Affected systems

Is your version affected?

Pick the product and type the version you run. It's compared with this record's version ranges in your browser; the version isn't sent anywhere.

VendorProduct
ibmaspera faspex
linuxlinux kernel

Versions reported by the vendor

Affected version ranges reported by the assigning authority (ibm). Independent of NVD's CPE analysis and usually ahead of it.

  • IBM Aspera Faspex

    • 5.0.0 and later · up to and including 5.0.19affected · semver

Affected versions

NVD version ranges (for catalog products). Add the product to your stack with a version and matching uses these.

  • ibm aspera faspex5.0.0 and later · before 5.0.19.1

Same product

ibm: all records

Other highest-scoring records for the same primary product.

Published before and after this one in the same product

  • ← EarlierCVE-2026-14958Jul 28, 2026 · OS command injection in IBM Aspera Faspex
    28Monitor
  • ← EarlierCVE-2026-14959Jul 28, 2026 · OS Command Injection in IBM Aspera Faspex
    28Monitor
  • ← EarlierCVE-2026-14996Jul 28, 2026 · Multiple vulnerabilities in IBM Aspera Faspex
    32Monitor

Remediation

Which version to upgrade to

Fix versions compiled from the vendor, package registries and Microsoft. Verify the vendor's note before upgrading.

No fix version is recorded for this entry. Check the references for vendor advisories.

Exploit status

Weaponized

A ready exploit tool or active in-the-wild use is known for this vulnerability. This should be your top priority.

Evidence

  • Proof-of-concept repository on GitHub ×1

Noroxi does not host or link to exploit code. Metasploit module names and Nuclei template ids are shown (names, not code); Exploit-DB entries and PoC repositories are given as counts only.

Public exploit evidence
SourceKindDate
Proof-of-concept repository on GitHubstars:02026-11-10

Research context

For pentesters and researchers: attack profile, score disagreement, timeline, patch commits, credits, variant and chain candidates, bug bounty scope. All derived from existing data; no exploit code.

Timeline

From publication to today: proof of concept, Metasploit module, CISA KEV and fix record. Dates are as reported by the sources.

  1. Published
  2. CISA KEV+2 d
  3. First PoC+3 d
  4. TodayNov 13, 2026+7 d
EPSS, last 120 days

FIRST EPSS daily score; only changes of 0.01 or more are recorded (step chart).

Bug bounty scope

The product’s vendor appears in a public program. Matched by name; verify the scope text in the program.

Not on record for this CVE: patch commit or PR link · researcher credit · variant or chain candidate.

Technical details

Attack conditions

  • Anyone who can reach it over the internet can trigger it.
  • No account or password is required.
  • No user action is required.
  • No special conditions are required; it is repeatable.

If successful

Confidentiality
high · data can be read
Integrity
high · data or configuration can be modified
Availability
high · the service can be disrupted
Attack vector
Network
Attack complexity
Low
Privileges required
None
User interaction
None
Scope
Unchanged
Confidentiality impact
High
Integrity impact
High
Availability impact
High

Weakness class (CWE)

CWE-863 · Incorrect Authorization

CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

nvd-secondary

Attack context

MITRE CAPEC attack patterns and ATT&CK techniques for this weakness class (CWE). A starting point for detection rules and threat hunting.

MITRE has no CAPEC/ATT&CK mapping for this CWE.

Change log

  1. Exploit maturitynone → weaponized
  2. KEV✗ → ✓
  3. SSVC exploitation— → active
  4. Exploit maturity— → none

For records you follow, these changes also arrive as notifications. →

References

Show all references (1 more)

Vendor advisories and official records. Exploit/PoC links are deliberately left out.

All records